Zyneyro ApS: Financial statements 2021
CVR: 42057428
Source: annual report 2021, Danish Business Authority
26/01/2021 – 31/12/2021
Zyneyro ApS (CVR 42057428) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -27,125 and a net result of DKK -29,101. Equity in the 2021 report amounted to DKK 10,899. The solvency ratio was 2.3%.
- Gross Profit
- DKK -27,125
- Profit/Loss
- DKK -29,101
- Equity
- DKK 10,899
- Total Assets
- DKK 463,899
- Employees
- 0
Official annual report
Find more companies like Zyneyro ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
As of February 15, 2021, Ulrik Gether has joined the board of directors of Zyneyro ApS.
As of February 15, 2021, Kenneth Lindegaard Madsen has joined the board of directors of Zyneyro ApS.
As of February 15, 2021, Peter Horn Møller has left the board of directors of Zyneyro ApS.
As of January 26, 2021, City Administration II ApS has been appointed auditor of Zyneyro ApS.
As of January 26, 2021, Jacob Ørndrup has joined the board of directors of Zyneyro ApS.
As of January 26, 2021, Peter Horn Møller has joined the board of directors of Zyneyro ApS.
As of January 26, 2021, Andreas Toft Sørensen has joined the board of directors of Zyneyro ApS.
As of January 26, 2021, Peter Horn Møller is registered as director of Zyneyro ApS.
Zyneyro ApS was founded on January 26, 2021.
About Zyneyro ApS
Zyneyro ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2021. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named DolorestBio ApS. The management consists of Steen Søren Klysner. The board consists of Jacob Ørndrup (chair), Andreas Toft Sørensen, Erik Vinther and Kenneth Lindegaard Madsen. The company's owners include Marigold Innovation ApS, IFO ApS and UGether ApS. The company has 10 employees (2026). In 2025, the company reported a gross profit of DKK -4,550,684 and a net result of DKK -7,466,446 compared with DKK 665,931 the year before. Equity in the 2025 report amounted to DKK 4,147,370.